Your browser doesn't support javascript.
loading
Illuminating the understudied GPCR-ome.
Majumdar, Sreeparna; Chiu, Yi-Ting; Pickett, Julie E; Roth, Bryan L.
Affiliation
  • Majumdar S; Department of Pharmacology, UNC Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA.
  • Chiu YT; Department of Pharmacology, UNC Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA.
  • Pickett JE; Department of Pharmacology, UNC Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA.
  • Roth BL; Department of Pharmacology, UNC Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA. Electronic address: bryan_roth@med.unc.edu.
Drug Discov Today ; 29(3): 103848, 2024 Mar.
Article in En | MEDLINE | ID: mdl-38052317
ABSTRACT
G-protein-coupled receptors (GPCRs) are the target of >30% of approved drugs. Despite their popularity, many of the >800 human GPCRs remain understudied. The Illuminating the Druggable Genome (IDG) project has generated many tools leading to important insights into the function and druggability of these so-called 'dark' receptors. These tools include assays, such as PRESTO-TANGO and TRUPATH, billions of small molecules made available via the ZINC virtual library, solved orphan GPCR structures, GPCR knock-in mice, and more. Together, these tools are illuminating the remaining 'dark' GPCRs.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Biological Assay / Receptors, G-Protein-Coupled Limits: Animals / Humans Language: En Year: 2024 Type: Article

Full text: 1 Database: MEDLINE Main subject: Biological Assay / Receptors, G-Protein-Coupled Limits: Animals / Humans Language: En Year: 2024 Type: Article